StemExpress is providing molecular and serology testing via Emergency Use Authorization (EUA) from the FDA. Our services are available for healthcare systems, employers, municipalities and members of the community. All molecular tests are run in our high-complexity CLIA laboratory in Folsom, CA.
We have the ability to provide a turn-key solution for on-site testing for employers (minimum requirements) including scheduling, registration, consenting, specimen collection, testing, data generation, and result reporting. Specimen collections and COVID-19 testing can be done on-site or at a specified StemExpress location.
Molecular Testing (RT-PCR)
Samples will be collected from participants and sent to our CLIA laboratory for RT-PCR testing using Thermo Fisher’s Applied Biosystems TaqPath™ Assay technology. This highly sensitive diagnostic test provides fast and reliable results. Through this testing, positive results are indicative of a current SARS-CoV-2 infection.
Antibody Testing is a serological test for the qualitative detection of antibodies against SARS-CoV-2 in the blood. A blood draw is required to collect a sample for an antibody test. The presence of the antibodies can identify participants that may have been infected at a previous point in time.
Please be aware that the results from the Molecular or Antibody tests, whether positive or negative, must be combined with clinical observations, patient history, and epidemiological information for a proper medical diagnosis.